We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$624M
AUM Growth
-$27.5M
Cap. Flow
-$61.2M
Cap. Flow %
-9.81%
Top 10 Hldgs %
33.44%
Holding
347
New
82
Increased
36
Reduced
39
Closed
74

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$27.7M
2
CYBR
CyberArk
CYBR
+$19.8M
3
GTLS
Chart Industries
GTLS
+$18.3M
4
WNS
WNS Holdings
WNS
+$14.3M
5
AL
Air Lease Corp
AL
+$11M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$31.3M
2
BPMC
Blueprint Medicines
BPMC
+$23.5M
3
AMED
Amedisys
AMED
+$22.1M
4
JNPR
Juniper Networks
JNPR
+$18.6M
5
SKX
Skechers
SKX
+$18.2M

Sector Composition

Rank Sector Weight
1 Communication Services 17.36%
2 Technology 16.91%
3 Industrials 12.22%
4 Healthcare 11.95%
5 Financials 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMC icon
201
Vulcan Materials
VMC
$36.5B
$246K 0.04%
800
– –
KD icon
202
Kyndryl
KD
$2.84B
$243K 0.04%
8,100
– –
TIGO icon
203
Millicom
TIGO
$16.2B
$243K 0.04%
5,000
-1,000
-17% -$43.9K
BBIO icon
204
BridgeBio Pharma
BBIO
$16.4B
$234K 0.04%
+4,500
New +$219K
ANET icon
205
Arista Networks
ANET
$264B
$233K 0.04%
+1,600
New +$206K
TXT icon
206
Textron
TXT
$15.3B
$228K 0.04%
2,700
– –
BAX icon
207
Baxter International
BAX
$14.1B
$228K 0.04%
10,000
– –
F icon
208
Ford
F
$55.3B
$215K 0.03%
18,000
– –
ITT icon
209
ITT
ITT
$19.4B
$215K 0.03%
+1,200
New +$201K
HCA icon
210
HCA Healthcare
HCA
$90.2B
$213K 0.03%
+500
New +$194K
FLS icon
211
Flowserve
FLS
$10.3B
$213K 0.03%
+4,000
New +$217K
CWB icon
212
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.71B
$204K 0.03%
+2,250
New +$194K
AOUT icon
213
American Outdoor Brands
AOUT
$160M
$187K 0.03%
21,500
– –
WHG icon
214
Westwood Holdings Group
WHG
$184M
$173K 0.03%
10,500
-500
-5% -$8.61K
ARLO icon
215
Arlo Technologies
ARLO
$1.53B
$170K 0.03%
10,000
– –
MGRM
216
DELISTED
Monogram Orthopaedics
MGRM
$145K 0.02%
+24,700
New +$132K
CAEP
217
DELISTED
Cantor Equity Partners III
CAEP
$142K 0.02%
13,800
– –
CVAC
218
DELISTED
CureVac
CVAC
$140K 0.02%
26,050
– –
FCRS.U
219
FutureCrest Acquisition Corp Units
FCRS.U
$139K 0.02%
+13,100
New +$138K
BLZRU
220
Trailblazer Acquisition Corp Unit
BLZRU
$137K 0.02%
+13,400
New +$135K
LION icon
221
Lionsgate Studios
LION
$3.48B
$131K 0.02%
19,025
+1,940
+11% +$12.5K
OCSAW
222
Oculis Holding AG Warrants
OCSAW
$260M
$126K 0.02%
18,601
– –
CCCXW
223
DELISTED
Churchill Capital Corp X Warrants
CCCXW
$124K 0.02%
+35,050
New +$51.3K
NABL icon
224
N-able
NABL
$614M
$121K 0.02%
15,500
– –
WEN icon
225
Wendy's
WEN
$1.61B
$119K 0.02%
13,000
– –
7 8
9
10 11

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
LCM
Lonestar Capital Management San Francisco, California $671M AUM 72.56% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, Gabelli & Co Investment Advisers held 347 positions worth $624M, down 4.2% from $651M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $61.2M in Q3 2025, closing 74 positions and reducing 39 holdings. Its most notable exit was Hess, an estimated $31.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Verona Pharma worth $28.3M.

  • Gabelli & Co Investment Advisers's largest Q3 2025 buy was Verona Pharma: 265,266 shares worth $28.3M.
  • Gabelli & Co Investment Advisers added most to Chart Industries in Q3 2025, an estimated $18.3M increase.
  • Gabelli & Co Investment Advisers's biggest Q3 2025 reduction was Telephone and Data Systems, cutting an estimated $5.3M.
  • Gabelli & Co Investment Advisers fully exited Hess in Q3 2025, selling an estimated $31.3M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $624M portfolio in Q3 2025.
  • Gabelli & Co Investment Advisers opened 82 new positions and closed 74 in Q3 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 4.2% quarter-over-quarter to $624M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.